Skip to content

Exploratory study of individual differences in the weight loss effect of exercise intervention on obese people [Trial No. g2022005]

Exploratory study of individual differences in the weight loss effect of exercise intervention on obese people [Trial No. g2022005] - Exploratory study of individual differences in the weight loss effect of exercise intervention on obese people [Trial No. g2022005]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048462
Enrollment
60
Registered
2022-07-26
Start date
2022-08-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Exercise guidance for weight loss and visceral fat reduction will be provided once every two weeks for two months. After that, a follow-up period will be set for one month.

Sponsors

Macromill,Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Obese or lightly obese (Body Mass Index [BMI] >=25. If insufficient number of subjects, BMI >=23). (2) Subjects who have a diet intention. (3) Subjects who have a smartphone and can record meals and write a life diary using the app.

Exclusion criteria

Exclusion criteria: (1) Subjects currently receiving drug treatment due to some chronic disease. (2) Subjects who have a history or current history of diseases such as liver disease, renal disease, respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, mental disease, cancer, infectious disease, and arrhythmia. (3) Alcoholic drinkers. (4) Subjects with a history of gastrointestinal resection. (5) Subjects who collected 200 mL of blood within 1 month or 400 mL or more within 3 months of the start of this study. (6) Subjects who have skin diseases (atopic dermatitis, acne vulgaris, psoriasis, etc.) on face. (7) Subjects who use medical external medicine on the face. (8) Subjects who have excessive sunburn on the face. (9) Subjects who have skin diseases, metal allergies, pacemakers, etc. in their bodies. (10) Subjects who plan to participate in other clinical trials during the trial participation period. (11) Subjects who are not day shifts such as night shifts and rotation shifts (12) Subjects who have felt sick at the time of blood collection, or those who have difficulty in collecting blood because the blood vessels in the arm are difficult to see. (13) Subjects who have a history of drug dependence, alcohol dependence, or current medical history. (14) During the two weeks prior to the visit to the test site, the patient or his / her family members had mild wind symptoms such as fever, cough, and sore throat, high fever, dyspnea, and strong fatigue. Those who have or are currently having dysgeusia or olfactory dysfunction. (15) Subjects who plan to travel or travel for more than 2 weeks during the test period. (16) Subjects with low physical fitness who cannot exercise moderately, or subjects who have orthopedic area disease or orthopedic area chronic disease. (17) Subjects deemed inappropriate to participate in this study by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Analysis of the relationship between weight loss / visceral fat loss before and after the intervention and other measurement items (physical test, blood test, etc.)

Secondary

MeasureTime frame
Comprehensive relevance analysis of all measurement items

Countries

Japan

Contacts

Public ContactTakahihro Hasumura

Kao Corporation Biological Science Research laboratories

hasumura.takahiro@kao.com+81-3-5630-7268

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026